Icure Pharmaceutical (XKRX:175250) Selling and Marketing Expense : ₩9,381 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Icure Pharmaceutical Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Icure Pharmaceutical's Selling and Marketing Expense for the three months ended in Dec. 2024 was ₩1,908 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩9,381 Mil.

Icure Pharmaceutical Selling and Marketing Expense Historical Data

The historical data trend for Icure Pharmaceutical's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icure Pharmaceutical Selling and Marketing Expense Chart

Icure Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Selling and Marketing Expense

Get a 7-Day Free Trial

18,487.99

6,987.76

3,920.67

7,057.58

9,381.32

Icure Pharmaceutical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Selling and Marketing Expense	Get a 7-Day Free Trial															3,101.08	2,914.51	1,984.85	2,573.80	1,908.16

Icure Pharmaceutical Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩9,381 Mil.

Icure Pharmaceutical Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Icure Pharmaceutical's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Icure Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Icure Pharmaceutical Inc (XKRX:175250) » Definitions » Selling and Marketing Expense

Traded in Other Exchanges

N/A

Address

7, Saimdang-ro 1-gil, Seocho-gu, Seoul, KOR

Website

https://www.icure.co.kr

Icure Pharmaceutical Inc operates as a biopharmaceutical company engages in the development and commercialization of novel transdermal drug delivery formulation. It also developed and commercialized various patches and hydrogels for the treatment of rheumatic arthritis pain, nicotine replacement therapy, medicated wound dressings, skin care, and dental care. The products pipeline is also aimed at the development of prescription drugs to diseases of the central nervous system, asthma, and pain.

Icure Pharmaceutical Headlines

No Headlines